Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

1(17%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_4

17%

Ph phase_1

50%

Ph not_applicable

17%

Ph phase_3

17%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 1Safety & dosage

3(50.0%)

Phase 3Large-scale testing

1(16.7%)

Phase 4Post-market surveillance

1(16.7%)

N/ANon-phased studies

1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(4)

Other(1)

Detailed Status

Completed4

unknown1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 13 (50.0%)

Phase 31 (16.7%)

Phase 41 (16.7%)

N/A1 (16.7%)

Trials by Status

unknown117%

completed467%

recruiting117%

Recent Activity

1 active trials

Showing 5 of 6

recruitingphase_1

The Role of 5-HT2A Receptor in the Perception of Self and Personal Meaning in Healthy Volunteers

NCT02451072

completedphase_1

Efficacy of Pirfenidone Plus MODD in Diabetic Foot Ulcers

NCT02632877

View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials

NCT03289949Phase 1

The Neurobiological Effect of 5-HT2AR Modulation

Recruiting

NCT04558294Phase 1

Effect of Ketanserin After LSD Administration

Completed

NCT03646318Phase 4

Ketanserin Effects on Peripheral Temperature and Lactate

Unknown

NCT02451072Not Applicable

The Role of 5-HT2A Receptor in the Perception of Self and Personal Meaning in Healthy Volunteers

Completed

NCT02632877Phase 1

Efficacy of Pirfenidone Plus MODD in Diabetic Foot Ulcers

Completed

NCT01329887Phase 3

The Effect of Ketanserin on the Microcirculation in Sepsis

Completed

All 6 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 6